Genetic Engineering Offers Painless "Shots" For Cattle

October 01, 1997

MANHATTAN -- For Kansas cattle, getting vaccinated may become as simple as eating fodder. Researchers at Kansas State University are developing a vaccine for calf enteric disease that will not be delivered as a shot. It will instead immunize cattle through the alfalfa they eat.

Sanjay Kapil, assistant professor of diagnostic medicine, heads the effort to genetically express proteins for the bovine corona and bovine rota viruses in plants. With traditional vaccinations, farmers directly inject cattle with non-infective virus protein. This produces antibodies that help fight disease. However, Kapil explains that this process is a hassle for ranchers.

"If you inject too much of the virus, the cattle will get sick. But by delivering vaccines with plants, the cattle will never get sick." This is because the plant vaccines do not have concentrations of infectious virus. Anyone who has struggled with capturing and injecting a calf with a needle will recognize the convenience the new vaccines will provide.

Researchers must first insert the genes of the virus into the plant chromosomes so that it will become a permanent part of the plant's genetic code. The ultimate goal is expressing the new vaccination gene in successive generations of plants, which can then be fed to animals.

Kapil explains that smaller trials represent the first step in the overall process. "Before we go into large scale animal trials, we need to do it in a lab system. So we chose tobacco plants and the mouse, which are easier to work with in the lab." The team has successfully integrated the vaccine in tobacco plants and fed those plants to mice. Now, they are simply waiting for the results.

Though the Kansas State team moved first in bovine vaccinations, researchers had already begun expressing vaccination genes in plants for human consumption. Knowing the results of their trials, Kapil expects the same positive results for cattle. The next step will be actual field trials, taking vaccines into fodder crops, like alfalfa, and giving it to cattle. Field trials could be as little as five years away.

Plant vaccines will help Kansas farmers and ranchers, but the significance of this research stretches far beyond its cattle ranches. Enteric diseases like corona and rota cost more than $3 billion worldwide, infecting and killing young cattle with diarrhea. Ranchers in the United States lose $250 million annually to the viruses.

Kapil expects this research to help many related projects.

"We have crossed the boundaries of just the animal group." He explains that a similar rota virus invades human babies, as well as cattle, leading to infection in 750 million children each year. If the bovine vaccination proves effective, a similar technique may be developed for children.

Because of this exciting potential, the K-State team is applying for a patent. While similar procedures have been patented, Kapil feels this his team's genetic engineering is unique. "Every system is different: which gene to go after, how to deliver it, which crop, how to deliver it in the crop. We're very lucky. The initial results are very promising."

Kapil says his team's research is "a storybook of daydreams." For cattle and farmer alike, gene vaccines would be a dream come true.

For more information, contact Dr. Sanjay Kapil at (785) 532-4457. Prepared by Christina Foust.

Kansas State University

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to